What peptides can I take with a GLP-1 like semaglutide or tirzepatide?

The peptides people most commonly add are a growth hormone secretagogue pair, Ipamorelin and CJC-1295, for lean-mass support, and BPC-157 or TB-500 for gut and connective-tissue recovery. None of these has been tested in a controlled trial alongside a GLP-1. The rationale for each is mechanistic, not proven in combination, so "can" is a legal and practical question more than a safety-data one.

Do I actually need a peptide alongside a GLP-1?

Most people do not. Semaglutide or tirzepatide alone produces meaningful, sustained weight loss for the majority of users. A peptide add-on makes the most sense for a specific goal, usually preserving muscle at a higher dose or over a longer run, not as a default. Run the GLP-1 alone for a few months first and let the results tell you whether you need more.

What's the difference between BPC-157/TB-500 and Ipamorelin/CJC-1295 as GLP-1 add-ons?

They target different problems. BPC-157 and TB-500 are pitched for gut healing and soft-tissue recovery, on the theory that they counter GLP-1 nausea and support joints during a cut. Ipamorelin and CJC-1295 pulse natural growth hormone, which has a more direct mechanistic link to preserving lean mass while a GLP-1 drives rapid weight loss. Neither pair has combination trials with a GLP-1, but the muscle-preservation rationale for GH secretagogues rests on firmer physiology than the gut-repair case for BPC-157.

Is MOTS-c legal to add to a GLP-1 stack right now?

It sits in regulatory limbo. MOTS-c is not FDA-approved and is currently under review by the Pharmacy Compounding Advisory Committee, which held a hearing on July 23-24, 2026 on whether to add it to the 503A bulk substances list. FDA staff recommended against inclusion ahead of that hearing. Until the agency issues a final decision, licensed 503A compounding is not clearly available, and research-chemical sources are not a legal or quality-controlled option.

What is the most evidence-backed way to prevent muscle loss on a GLP-1?

Adequate protein intake and resistance training, not a peptide. Body-composition data across semaglutide and tirzepatide trials consistently shows lifting plus sufficient protein preserves lean mass more reliably than anything else tested. The ongoing LEAN-PREP trial (NCT06885736) is measuring this directly. If you want a peptide on top of that foundation, treat it as a supplement to the boring stuff, not a replacement for it.

Home / Peptides & Longevity / Peptides to Take With a GLP-1

The Compound — Peptides

Peptides to take with a GLP-1: what actually pairs, and what's just marketing

Every peptide clinic and Instagram ad has an opinion about what to stack with your GLP-1. Almost none of them mention that most of these combinations have never been tested together in a human trial. Here is what each add-on actually claims, what backs it up, and what does not.

The CompoundJuly 17, 20268 min read

The gist

No peptide on this list has a controlled trial testing it alongside semaglutide or tirzepatide. Every pairing is mechanistic reasoning, not proven combination data.
Ipamorelin/CJC-1295 has the strongest rationale for muscle preservation. BPC-157 and TB-500 have strong animal data for tissue repair but no human trials at all, on their own or with a GLP-1.
MOTS-c is in active regulatory limbo as of July 2026, with an FDA advisory hearing underway on whether to allow it as a compounded substance.
The single most evidence-backed muscle-preservation strategy during GLP-1 treatment is protein plus resistance training, not a peptide.

Why people look for a peptide to take with a GLP-1

A GLP-1 alone does most of the work. Semaglutide and tirzepatide reliably produce 15 to 22.5 percent average weight loss on their own, and most people who stay on one long enough never add anything else. The people who go looking for a peptide add-on usually have one of three specific complaints: nausea that will not settle, joints and tendons that feel worse as the weight comes off faster than the body adapts, or a body-composition scan showing more lean mass loss than they expected.

Those complaints are real. The body-composition literature is consistent that a meaningful share of GLP-1 weight loss, commonly a quarter to nearly 40 percent depending on the drug and study, is lean mass rather than fat. That is the actual opening for an add-on. The question is whether any specific peptide closes it, and the honest answer varies a lot by compound.

Growth hormone secretagogues: the strongest muscle case

Ipamorelin and CJC-1295 are usually run together. Ipamorelin triggers a clean pulse of natural growth hormone without much effect on cortisol or appetite hormones, and CJC-1295 extends how long that pulse lasts. The pairing is popular in peptide clinics specifically as a counter to GLP-1 muscle loss, and the physiology behind it, growth hormone signaling supporting protein synthesis, is well established on its own.

What is missing is a trial that puts this pair alongside a GLP-1 and measures the outcome directly. Everyone extrapolating a muscle-sparing benefit here is reasoning from separate bodies of evidence, GH secretagogue physiology in one lane and GLP-1 body composition data in another, and assuming they add up cleanly. That is a reasonable bet. It is not a tested one.

BPC-157 and TB-500: the recovery and gut case

BPC-157 and TB-500 get pitched for a different reason: soothing the GI side effects of a GLP-1 and supporting tendon and connective-tissue recovery during a fast cut. Both have a decade of rodent data showing real tissue-repair effects. Neither has a large, controlled human trial behind it, on its own, let alone paired with a GLP-1. We cover that gap in detail in our piece on stacking BPC-157 with semaglutide or tirzepatide.

The pairing logic is intuitive: take the thing that heals gut tissue in animals while taking the drug that irritates gut tissue in people. Intuitive is not the same as demonstrated. No interaction has been documented between BPC-157 or TB-500 and any GLP-1, but that also means no one has looked closely enough to rule one out.

MOTS-c: the metabolic wildcard tangled in regulation

MOTS-c is a mitochondrial-derived peptide studied mostly as an exercise mimetic, improving insulin sensitivity and metabolic flexibility in early human and animal work. The pitch for pairing it with a GLP-1 is metabolic rather than structural: where Ipamorelin targets muscle and BPC-157 targets tissue repair, MOTS-c targets the cellular energy machinery that determines how efficiently a body burns fuel during weight loss.

Right now the more pressing issue is not evidence, it is legality. MOTS-c is caught in the same regulatory process as BPC-157: the FDA's Pharmacy Compounding Advisory Committee held a two-day hearing on July 23-24, 2026 to decide whether it belongs on the 503A bulk substances list, and agency staff recommended against adding it ahead of that hearing. Until a final decision lands, there is no clean path to a licensed, quality-controlled version of this peptide. Our full rundown of the mechanism and the hearing is in what is MOTS-c.

Ranking the evidence, honestly

StrongestProtein + resistance training. Directly measured in GLP-1 body-composition trials, no peptide required.

PlausibleIpamorelin/CJC-1295. Solid GH physiology on its own; no trial testing it alongside a GLP-1.

UnprovenBPC-157/TB-500. Strong rodent data for tissue repair; no controlled human trials, alone or combined.

Early and unsettledMOTS-c. Interesting mechanism, thin human data, and an active FDA hearing on whether it can be legally compounded at all.

Access and legality in 2026

For any peptide beyond the GLP-1 itself, legal access runs through a licensed 503A compounding pharmacy with a physician's prescription, not a research-chemical website. That rule has been tightening, not loosening. The FDA reclassified BPC-157 within the 503A framework in April 2026, and MOTS-c's status was still pending a committee decision as of this writing. A legitimate compounder will provide a Certificate of Analysis confirming potency and purity without being asked. If a source cannot produce one, that is the answer to whether it is a serious option.

The unglamorous thing that actually works

If the goal is protecting muscle specifically, the best-supported intervention is not on this list at all. Adequate protein intake and resistance training show up consistently across the GLP-1 body-composition literature as the difference between losing mostly fat and losing a lot of muscle along with it. The ongoing LEAN-PREP trial is measuring that combination directly in people on semaglutide and tirzepatide, and early observational data already points the same direction.

None of that means a peptide add-on is pointless. It means the foundation is a prescription that fits you, a sane dose schedule, enough protein, and consistent training. A peptide is an optional layer stacked on top of a decision that does most of the actual work, not a substitute for it. Our full peptide stack guide walks through specific combinations by goal if you want to go further.

Frequently Asked Questions

Get the 2026 GLP-1 Cost & Eligibility Cheat Sheet

One page: real monthly costs for compounded vs brand semaglutide and tirzepatide, the BMI thresholds that qualify you, and the five questions to ask before you pay. We'll email it now.

No spam. Unsubscribe anytime.

Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Peptides and GLP-1 medications require a prescription and should only be taken under the supervision of a licensed healthcare provider. Individual results vary. Always consult a doctor before starting any new medication or compound.

Sources

Full peptide stack guide →BPC-157 with a GLP-1 →How much GLP-1 weight loss is muscle? →What is MOTS-c? →